Opendata, web and dolomites

GLIODIABESITY SIGNED

ROLE OF THE TANYCYTIC BARRIER AT THE BLOOD-HYPOTHALAMUS INTERFACE DURING METABOLIC DISORDER DEVELOPMENT

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GLIODIABESITY project word cloud

Explore the words cloud of the GLIODIABESITY project. It provides you a very rough idea of what is the project "GLIODIABESITY" about.

collaborations    diabetes    obesity    appetite    fail    transport    brain    treating    formative    human    laboratory    hypothalamus    strengthen    molecular    genetically    age    administration    signals    circulating    adiposity    critical    deficient    demonstrated    patients    expenditure    conduit    paradoxically    underlying    neural    pathophysiology    borne    sites    limiting    solid    metabolic    onset    elucidate    obese    scientific    action    fat    besides    raises    modified    reduce    body    glia    barriers    therapeutic    mechanism    models    mechanisms    insulin    reduces    fluid    regulate    death    mice    possibility    boosting    hyperphagia    diseases    diet    blunted    contents    closer    tanycytes    hypothalamic    alteration    humans    resistance    proportion    barrier    homeostasis    clinical    csf    defective    vitro    ventricle    endowed    expand    combination    display    responsible    levels    shuttling    convey    cerebrospinal    periphery    networks    vivo    anticipated    leptin    play    career    energy    host    lining    hold    blood    paving    floor    disorders   

Project "GLIODIABESITY" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITE DE LILLE II - DROIT ET SANTE 

There are not information about this coordinator. Please contact Fabio for more information, thanks.

 Coordinator Country France [FR]
 Project website http://hypothalamus.eu/
 Total cost 173˙076 €
 EC max contribution 173˙076 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2017-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITE DE LILLE FR (LILLE) coordinator 173˙076.00
2    UNIVERSITE DE LILLE II - DROIT ET SANTE FR (Lille) coordinator 0.00

Map

 Project objective

Metabolic disorders such as obesity and diabetes are age-related diseases, and lead cause of death in Europe. Adiposity signals such as leptin and insulin, whose circulating levels are in proportion to body fat, convey metabolic information to neural networks that regulate energy homeostasis in the hypothalamus. In leptin-deficient humans and mice, leptin administration effectively reduces hyperphagia and obesity. Paradoxically, most cases of obesity display high circulating leptin levels that fail to reduce appetite or increase energy expenditure. This raises the possibility that leptin transport across the blood-brain barrier to the cerebrospinal fluid (CSF) or to its sites of action within the hypothalamus is a limiting step defective in obese patients. The host laboratory recently demonstrated that tanycytes, a hypothalamic glia lining the floor of the third ventricle, were responsible for shuttling leptin from the periphery to the CSF and that such conduit was blunted in mice with diet-induced obesity. Leptin transport by tanycytes could thus play a critical role in the pathophysiology of leptin resistance. The overall objective of this project is to further elucidate whether the alteration of the adiposity signals transport into the metabolic brain across hypothalamic barriers is the main cause of the onset of obesity. To this end, a combination of in vitro and in vivo approaches, using genetically modified mice and pre-clinical models of obesity, will be implemented in order to elucidate the molecular mechanisms for the transport of blood-borne leptin into the CSF by tanycytes. It is anticipated that implementation of this project will expand our knowledge of the mechanism underlying human obesity and hold therapeutic potential for treating it. Besides, the proposed project is endowed of solid formative contents that will strengthen the experience of the applicant, boosting her future scientific career and paving the way for closer scientific collaborations.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GLIODIABESITY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GLIODIABESITY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

BIOplasma (2019)

Use flexible Tube Micro Plasma (FµTP) for Lipidomics

Read More  

MY MITOCOMPLEX (2021)

Functional relevance of mitochondrial supercomplex assembly in myeloid cells

Read More  

ErgThComplexSys (2020)

Ergodic theory for complex systems: a rigorous study of dynamics on heterogeneous networks

Read More